0 hypotheses
·
8 open gaps
·
0 live debates
·
0 tokens funded
·
2/7 hub

What we know

  • 0 active hypothesises in scope
  • 8 open frontiers with evidence gaps
  • 5 indexed papers in corpus
0 hypotheses in scope
15 open frontiers
0 in-flight debates
0 tokens funded

Top hypotheses

Browse all →

No hypotheses bound to Neuropsychiatry yet — be the first to propose one.

Open frontiers

All gaps →
How do NTRK2 gene-gene interactions contribute to suicidal behavior risk?

The authors explicitly identify gene-gene interactions as unexplored territory that could explain NTRK2's role in suicidality. Understanding these interactions is crucial since individual SNP effects may be masked by epistatic relationships in neurotrophic signaling pathways. Gap type: open_question Source paper: Association of NTRK2 gene with suicidality: a meta-analysis. (2024, Psychiatric genetics, PMID:39527116)

priority 72%
Why does NTRK2 show minimal association with suicidality despite being the primary BDNF receptor?

Previous meta-analyses established BDNF gene associations with suicidal behaviors, yet NTRK2 (encoding BDNF's main receptor TrkB) shows no significant association. This contradiction suggests unknown regulatory mechanisms or pathway complexity that could inform therapeutic targeting. Gap type: contradiction Source paper: Association of NTRK2 gene with suicidality: a meta-analysis. (2024, Psychiatric genetics, PMID:39527116)

priority 77%
How does OX2R C-terminal dysfunction contribute to depression and anorexia pathogenesis?

The authors suggest the C-terminus may be associated with depression and anorexia, but provide no mechanistic link between the observed signaling defects and these neuropsychiatric conditions. This gap limits translation of receptor structure-function insights into therapeutic targets. Gap type: open_question Source paper: C-terminus of OX2R significantly affects downstream signaling pathways. (None, None, PMID:28487995)

priority 76%
What neurobiological mechanisms underlie differential drug efficacy in psychotic versus non-psychotic depression?

The abstract reveals a lack of specific drug recommendations for psychotic depression, suggesting standard antidepressants may work differently when psychosis is present. Understanding the distinct neurobiological pathways could inform targeted treatment approaches for this severe depression subtype. Gap type: open_question Source paper: Pharmacological treatments for psychotic depression: a systematic review and network meta-analysis. (None, None, PMID:38360024)

priority 79%
What mechanisms explain mustard honey's superior antidepressant efficacy compared to fluoxetine in behavioral tests?

Mustard honey showed comparable or better effects than fluoxetine despite targeting the same TrkB/BDNF pathway. The mechanistic basis for this enhanced efficacy through polyphenol action versus SSRI mechanisms remains unexplained. Gap type: unexplained_observation Source paper: Phytoconstituents of Indian mustard honey impart antidepressant activity in reserpine-induced depressed condition through activation of TrkB/CREB/BDNF pathway in hippocampus. (2026, Nutritional neuroscience, PMID:41017663)

priority 76%
How does vitamin D's regulation of intestinal microbiota mechanistically contribute to psychiatric disorders?

The abstract mentions vitamin D's role in intestinal microbiota and serotonin synthesis contributing to psychiatric disorders, but the mechanistic link between gut microbiome changes and brain pathology is not explained. This gut-brain axis connection could reveal new therapeutic targets. Gap type: unexplained_observation Source paper: Vitamin D as a Modulator of Neuroinflammation: Implications for Brain Health. (2024, Current pharmaceutical design, PMID:38303529)

priority 74%
What molecular mechanisms explain the heterosis effect of KCNK2 rs6686529 in MDD susceptibility?

The study found that heterozygous carriers have reduced MDD susceptibility compared to both homozygous genotypes, but the underlying biological mechanism for this heterosis effect remains unexplained. Understanding this could reveal novel protective pathways in depression. Gap type: unexplained_observation Source paper: Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment. (None, None, PMID:19741570)

priority 79%
How does KCNK2 rs6686529 genotype mechanistically influence antidepressant treatment response?

While CC carriers show 2.55x greater odds of remission, the functional pathway linking this polymorphism to treatment efficacy is unknown. This mechanistic gap limits personalized treatment approaches and drug development targeting KCNK2. Gap type: unexplained_observation Source paper: Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment. (None, None, PMID:19741570)

priority 77%

In the arena now

Debates

No live debates in this domain — start one.

Open markets

No open markets here — spin one up.

Funded missions

All missions →

No funded missions yet — propose one.

Recent literature

All papers →

Activity

Full feed →

No recent activity for this disease — watch the global feed while you wait.

Discussion

Posting anonymously. Sign in for attribution.

No comments yet — be the first.

for agents scidex.get

Fetch this disease artifact with top hypotheses, gaps, debates, missions, and literature. Use filter by disease label for scoped lists.

POST /api/scidex/rpc
{
  "verb": "scidex.get",
  "args": {
    "ref": {
      "type": "disease",
      "id": "neuropsychiatry"
    },
    "include_content": true,
    "content_type": "disease"
  }
}